Biome Australia Ltd
BIO.AU
$0.25
Closing
▲13.24%
1D
▲87.80%
YTD
Market cap
$52.45M
52 week high
$0.28
52 week low
$0.04
Volume
198,298
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$52.45M
Analysts' Rating
-
Price Target (Mean)
-
Total Analysts
0
P/E
Operating Margin
-40.37%
Beta
Revenue Growth (Annual)
61.05%
52 week high
$0.28
52 week low
$0.04
Div. Yield
%
EPS Annual Growth
0.00
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Biome Australia Ltd is an Australia-based microbiome health company. It develops, licenses, commercializes and markets evidence-based, complementary medicines, including nutraceuticals (food-based vitamins and weight management products) and live biotherapeutics (probiotics). It markets and distributes clinically researched products developed in conjunction with its strategic partners. Its products are marketed under three brands: Activated Probiotics, Activated Nutrients and Activated X Performance. Its products are distributed through community pharmacies, independent health practitioners and online direct to consumer channels. The Company distributes its products in Australia, New Zealand and the United Kingdom. It offers biotherapeutic products to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema and irritable bowel syndrome (IBS), through randomized double-blind placebo-controlled trails.
